Valneva SE (VALN) Non-Current Assets (2020 - 2026)

Valneva SE (VALN) posted quarterly Non-Current Assets of $194.1 million for Q1 2026, down 12.61% year-on-year from $222.1 million in Q1 2025, and down 3.25% on a QoQ basis from $200.6 million in Q4 2025.

Valneva SE (VALN) Non-Current Assets (2020 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Non-Current Assets for 7 consecutive years, with $194.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Non-Current Assets fell 12.61% year-over-year to $194.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $813.3 million (down 11.4% YoY) and the FY2025 annual result came in at $200.6 million, down 12.3% from the prior year.
  • Non-Current Assets declined to $194.1 million in Q1 2026 per VALN's latest filing, from $200.6 million in the prior quarter.
  • Over the last five years, Non-Current Assets for VALN reached as high as $264.8 million in Q1 2022 and fell as low as $194.1 million in Q1 2026.
  • A 5-year average of $226.9 million and a median of $224.7 million in 2024 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2024 — Non-Current Assets climbed 6.56% — and 2025, when it fell 15.54%.
  • Year by year, Non-Current Assets stood at $223.8 million in 2022, then advanced by 0.28% to $224.4 million in 2023, then increased by 1.92% to $228.8 million in 2024, then slipped by 12.3% to $200.6 million in 2025, then fell by 3.25% to $194.1 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $194.1 million, $200.6 million, and $204.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 194.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 194.11 Mn
Dec 31, 2025 200.62 Mn
Sep 30, 2025 204.72 Mn
Jun 30, 2025 213.83 Mn
Mar 31, 2025 222.12 Mn
Dec 31, 2024 228.75 Mn
Sep 30, 2024 242.38 Mn
Jun 30, 2024 224.65 Mn
Mar 31, 2024 223.71 Mn
Dec 31, 2023 224.45 Mn
Sep 30, 2023 227.46 Mn
Jun 30, 2023 228.83 Mn
Mar 31, 2023 228.35 Mn
Dec 31, 2022 223.82 Mn
Sep 30, 2022 252.11 Mn
Jun 30, 2022 251.86 Mn
Mar 31, 2022 264.79 Mn
Dec 31, 2021 263.46 Mn
Dec 31, 2020 160.15 Mn